Gingerol Derivative Inhibits Pseudomonas aeruginosa Biofilm via LasR Binding

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Biofilms formed by microorganisms, such as Pseudomonas aeruginosa, are difficult to disinfect and sterilize due to their strong adherence to surfaces and resistance to environmental conditions and antibiotics, leading to challenges in treating infections caused by these biofilms.

Innovation Solution

A gingerol derivative with enhanced binding affinity for the LasR protein, disrupting the quorum sensing system of Pseudomonas aeruginosa, thereby inhibiting biofilm formation and reducing the production of virulence factors.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional antibiotics and disinfectants are used, then bacterial infections can be treated, but biofilm formation resists these treatments due to strong adherence and environmental resistance

Engineering Contradiction:
Improvetreatment efficacyVSAvoidbiofilm resistance
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The gingerol derivative is applied before biofilm formation is fully established to prevent the development of resistant biofilm structures. By disrupting quorum sensing early in the bacterial communication process, the treatment prevents the coordinated gene expression that leads to biofilm matrix production and antibiotic resistance, making the bacteria vulnerable to conventional treatments.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The gingerol derivative acts as an intermediary molecule that interferes with the quorum sensing signal transduction pathway. It binds to the LasR receptor protein, preventing the autoinducer molecules from activating the transcription of virulence and biofilm formation genes, thereby blocking the communication between bacterial cells without directly killing them.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If quorum sensing systems are disrupted to inhibit biofilm formation, then treatment efficacy improves, but the complexity of the QS network (LasI-LasR, RhlI-RhlR, PQS-MvfR) makes targeted intervention difficult

Engineering Contradiction:
Improvebiofilm inhibition efficacyVSAvoidquorum sensing network complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The complex quorum sensing network is segmented into discrete targetable components, with the invention specifically targeting the LasI-LasR system as a primary control point. By developing a molecule that specifically binds to LasR, the complex three-system network is reduced to manageable segments, allowing effective intervention at a critical upstream node that influences downstream Rhl and PQS systems.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The gingerol derivative modifies the binding parameters of the LasR receptor by competing with autoinducer molecules for the binding site. This changes the concentration threshold and affinity parameters of the quorum sensing system, shifting the activation curve and preventing the threshold concentration from being reached, thereby inhibiting the cascade of gene expressions without needing to disrupt the entire network architecture.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If stronger adhesives or coatings are used to prevent bacterial adherence, then biofilm formation is reduced, but the strong adherence of biofilms to surfaces makes removal difficult

Engineering Contradiction:
Improveanti-adhesion effectivenessVSAvoidsurface treatment complexity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The invention replaces mechanical/physical anti-adhesion approaches (such as surface coatings or textured surfaces) with a biochemical mechanism. Instead of modifying surface properties to prevent adherence, the gingerol derivative chemically interferes with the bacterial communication system that coordinates adherence and biofilm formation, substituting a chemical intervention for a physical one.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The gingerol derivative effectively inhibits biofilm formation and treats infections caused by biofilms by disrupting the quorum sensing system of Pseudomonas aeruginosa, improving treatment efficacy and preventing biofilm-related infections.

Implementation Method 1

During biofilm formation, bacterial cells communicate with one another by means of quorum sensing (QS) network. QS is a cell-to-cell communication system in which bacteria release and recognize chemical signals (autoinducers)

Methodology Applied
Scientific EffectQuorum sensing:

Implementation Method 2

A gingerol derivative with enhanced binding affinity for the LasR protein, disrupting the quorum sensing system of Pseudomonas aeruginosa

Methodology Applied
Scientific EffectMolecular binding:

Data Source

PatentUS11964935B2Gingerol derivative having inhibitory activity against biofilm formation and pharmaceutical composition comprising same as effective ingredient for preventing or treating biofilm-caused infection symptom
Publication Date: 2024.04.23 KOREA UNIV RES & BUSINESS FOUND
  • US11964935B2 patent drawing
  • US11964935B2 patent drawing
  • US11964935B2 patent drawing

AI summary

The present invention relates to a gingerol derivative having inhibitory activity against biofilm formation and a pharmaceutical composition for preventing or treating infections caused by biofilms including the gingerol derivative as an active ingredient. The gingerol derivative of the present invention exhibits significantly improved binding affinity for LasR and inhibitory activity against biofilm formation. Therefore, the gingerol derivative of the present invention can act on various membrane surfaces where biofilms tend to form and can effectively inhibit the formation of the corresponding biofilms. In addition, the use of the pharmaceutical composition according to the present invention can fundamentally prevent or treat a variety of infections caused by biofilms due to the presence of the gingerol derivative in the pharmaceutical composition.